Canesten 10% Vaginal Cream
Last Updated on eMC 11-Dec-2013 View document | Bayer plc Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 11-Dec-2013 and displayed until Current
Reasons for adding or updating:
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 23-Aug-2010 and displayed until 11-Dec-2013
Reasons for adding or updating:
- Change to side-effects
- Change to drug interactions
Updated on 23-Oct-2009 and displayed until 23-Aug-2010
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 17-Aug-2006 and displayed until 23-Oct-2009
Reasons for adding or updating:
- Change to date of revision
Updated on 24-Sep-2004 and displayed until 17-Aug-2006
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue